Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Trabattoni

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4Stefania Piconi, Daria Trabattoni, Veronica Rainone, et al.
AIDS (London, England)|February 25, 2003
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual menSergio Lo Caputo, Daria Trabattoni, Francesca Vichi, et al.
Perfusion|May 15, 2002
Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parametersAlberto Beretta, Hamid Hasson, Abby Samiabadi, et al.
Journal of Medical Virology|February 17, 2006
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapyElisabetta Tanzi, Susanna Esposito, Jelena Bojanin, et al.
Viruses|January 30, 2014
Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccinesAngela Berzi, Norbert Varga, Sara Sattin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2009
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of diseaseDaria Trabattoni, Marina Saresella, Michela Pacei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2021
ERAPs Reduce In Vitro HIV Infection by Activating Innate Immune ResponseIrma Saulle, Ivana Marventano, Marina Saresella, et al.
International Journal of Molecular Sciences|October 13, 2017
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related ResponsesRossella Talotta, Angela Berzi, Andrea Doria, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Antiviral Effect of Erdosteine in Cells Infected with Human Respiratory VirusesPierachille Santus, Sergio Strizzi, Fiammetta Danzo, et al.
HIV Clinical Trials|December 13, 2006
An immunological comparison of third companion in advanced drug-naive HIV-infected patientsGiuliano Rizzardini, Daria Trabattoni, Amedeo Capetti, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4Stefania Piconi, Daria Trabattoni, Veronica Rainone, et al.
AIDS (London, England)|February 25, 2003
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual menSergio Lo Caputo, Daria Trabattoni, Francesca Vichi, et al.
Perfusion|May 15, 2002
Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parametersAlberto Beretta, Hamid Hasson, Abby Samiabadi, et al.
Journal of Medical Virology|February 17, 2006
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapyElisabetta Tanzi, Susanna Esposito, Jelena Bojanin, et al.
Viruses|January 30, 2014
Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccinesAngela Berzi, Norbert Varga, Sara Sattin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2009
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of diseaseDaria Trabattoni, Marina Saresella, Michela Pacei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2021
ERAPs Reduce In Vitro HIV Infection by Activating Innate Immune ResponseIrma Saulle, Ivana Marventano, Marina Saresella, et al.
International Journal of Molecular Sciences|October 13, 2017
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related ResponsesRossella Talotta, Angela Berzi, Andrea Doria, et al.
Pathogens (Basel, Switzerland)|May 7, 2025
Antiviral Effect of Erdosteine in Cells Infected with Human Respiratory VirusesPierachille Santus, Sergio Strizzi, Fiammetta Danzo, et al.
HIV Clinical Trials|December 13, 2006
An immunological comparison of third companion in advanced drug-naive HIV-infected patientsGiuliano Rizzardini, Daria Trabattoni, Amedeo Capetti, et al.
Pageof 14